Sanjivani Paranteral Ltd has announced that the Company's R&D unit has developed in house New Product for remedy of Bird Flue Virus and other viruses such as Lassa Fever Virus, HIV (AIDS) Virus, Hepatitis B, Yellow Fever Virus under the Brand name "SANCIDAL". This product is a potent, non-polluting, environment and eco-friendly.
The product is having a world wide market for approx. US $ 3 Billion. The Company has already commercially launched the product in domestic market and negotiations are on way with MNCs for global market.
The stock was trading at Rs.37.20, up by Rs.3 or 8.77%. The stock hit an intraday high of Rs.37.75 and low of Rs.34.35. The total traded quantity was 49627 compared to 2 week average of 23736.